Samsung Bioepis’ Trastuzumab Prequalified By WHO

Ontruzant Is First Ever Biosimilar Prequalified By Organization

WHO
WHO Prequalifies Samsung Bioepis’ Trastuzumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products